| ID | Name | CAS | Data |
log10WS |
| 124-323-5 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3,5-triethyl-5-phenyl-
|
|
6 | -3.01 |
| 124-569-3 |
2-Pyrrolidinone, 3-hydroxy-1-methyl-5-(3-pyridinyl)-, (3R-trans)-
|
34834-67-8 |
6 | 0.71 |
| 125-229-9 |
Methyl chol-4-en-3-one-24-oate, oxime, TMS # 2
|
|
6 | -6.34 |
| 125-254-1 |
10H-Phenothiazin-3-ol, 10-[3-(dimethylamino)propyl]-, acetate (ester)
|
56438-23-4 |
6 | -4.51 |
| 10-629-2 |
1,8-Diaza-tricyclo[7.6.0.0*3,7*]pentadeca-3(7),8-dien-2-one
|
|
5 | -2.17 |
| 10-858-8 |
2,6-Pyridinedicarboxylic acid, 2-chloro-6-fluorophenyl isobutyl ester
|
|
5 | -5.17 |
| 10-906-4 |
Silane, [[(16«beta»,17«alpha»)-estra-1,3,5(10)-triene-3,16,17-triyl]tris(oxy)]tris[trimethyl-
|
57305-22-3 |
5 | -6.66 |
| 11-272-7 |
allo-Cholanic acid, 3«alpha»,12«alpha»-dihydroxy, Me-TMS
|
|
5 | -6.65 |
| 11-342-9 |
7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-
|
484-20-8 |
5 | -3.60 |
| 11-932-4 |
Benzeneacetic acid, «alpha»-methylene-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, endo-
|
500-55-0 |
5 | -2.25 |
| 12-819-9 |
Silane, (estra-1,3,5(10)-trien-3-yloxy)trimethyl-
|
29755-24-6 |
5 | -6.27 |
| 12-961-1 |
allo-Cholanic acid, 3«alpha»,12«alpha»-dihydroxy, Me-DMES
|
|
5 | -6.84 |
| 13-010-5 |
1,3-Dioxolo[4,5-c]acridin-6(11H)-one, 4,5-dimethoxy-11-methyl-
|
568-01-4 |
5 | -4.02 |
| 13-662-2 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-(1-methylbutyl)-5-(2-propenyl)-
|
28239-49-8 |
5 | -2.45 |
| 16-153-4 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1,3-dimethyl-5-(3-methylbutyl)-
|
28239-46-5 |
5 | -2.43 |
| 16-182-2 |
Cholan-24-oic acid, 3-[(trimethylsilyl)oxy]-, methyl ester, (3«alpha»,5«beta»)-
|
59953-47-8 |
5 | -6.40 |
| 16-203-8 |
1H-1,2,4-Triazole-1-ethanol, «beta»-[(2,4-dichlorophenyl)methylene]-«alpha»-(1,1-dimethylethyl)-,(E)-(±)-
|
|
5 | -4.61 |
| 16-807-8 |
Estra-1,3,5(10)-trien-17-one, 3-[(trimethylsilyl)oxy]-
|
|
5 | -5.41 |
| 18-200-9 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,3-dimethyl-butyl)-amine
|
|
5 | -4.63 |
| 18-293-7 |
2-Propen-1-ol, 3-(4-hydroxy-3-methoxyphenyl), bis-TMS
|
|
5 | -3.48 |
| 18-577-2 |
Trimethylsilyl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitro-benzoate
|
|
5 | -6.59 |
| 19-607-7 |
1,3,5(10)-Oestratriene-3,17«beta»-diol, 3-TMS-17-HFB
|
|
5 | -7.78 |
| 20-100-7 |
Hydrocinnamic acid, 2-phosphono-, p,p-diisopropyl c-methyl ester
|
116401-34-4 |
5 | -2.75 |
| 21-240-1 |
2,6-Pyridinedicarboxylic acid, 4-bromo-2-methoxybenzyl pentyl ester
|
|
5 | -5.71 |
| 21-578-7 |
6-Chloro-N-sec-butyl-1,3,5-triazine-2,4-diamine
|
37019-18-4 |
5 | -3.77 |
| 22-998-0 |
2,6-Pyridinedicarboxylic acid, isobutyl 5-methoxy-3-methylpent-2-yl ester
|
|
5 | -3.34 |
| 23-872-8 |
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-
|
20971-53-3 |
5 | -3.52 |
| 23-943-9 |
Morphinan, 7,8-didehydro-4,5-epoxy-17-methyl-3,6-bis[(trimethylsilyl)oxy]-, (5«alpha»,6«alpha»)-
|
55449-66-6 |
5 | -3.24 |
| 24-374-0 |
Phosphorothioic acid, O,O-diethyl S-[2-(ethylsulfonyl)ethyl] ester
|
|
5 | -1.25 |
| 26-988-7 |
6H-Purin-6-one, 2-amino-1,7-dihydro-7-methyl-
|
|
5 | -2.13 |
| 27-574-5 |
2-Pyridinecarboxylic acid, 4-amino-3,5,6-trichloro-, methyl ester
|
|
5 | -3.68 |
| 28-206-2 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-diethyl-5-(1-methylbutyl)-5-(2-propenyl)-
|
54833-76-0 |
5 | -2.95 |
| 28-564-5 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1,3,5-trimethyl-
|
726-79-4 |
5 | -2.63 |
| 29-616-6 |
3-Bromomethyl-6-bromo-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
|
3764-20-3 |
5 | -3.43 |
| 30-384-2 |
allo-Cholanic acid, 3«beta»,7«beta»-dihydroxy, Me-TMS
|
|
5 | -6.52 |
| 30-795-6 |
3,16,17-Tris[(trimethylsilyl)oxy]estra-1,3,5(10)-triene, (16«beta»,17«beta»)-
|
57305-21-2 |
5 | -6.66 |
| 31-275-2 |
2,6-Pyridinedicarboxylic acid, 3-methylbutyl 2-methylhex-3-yl ester
|
|
5 | -4.79 |
| 32-568-6 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1-methyl-5-phenyl-
|
|
5 | -2.57 |
| 33-042-8 |
2,6-Pyridinedicarboxylic acid, isobutyl 2,4,4-trimethylpentyl ester
|
|
5 | -5.26 |
| 33-267-9 |
1,3-Dioxolo[4,5-b]acridin-10(5H)-one, 11-hydroxy-4-methoxy-5-methyl-
|
|
5 | -3.85 |
| 34-250-6 |
5-(4-Chlorophenyl)-6-ethylpyrimidine-2,4-diamine, N,N'-bis(trifluoroacetyl)-
|
|
5 | -6.35 |
| 34-424-3 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1,3-dimethyl-5-(1-methylpropyl)-
|
55134-03-7 |
5 | -1.98 |
| 35-361-2 |
3-Amino-2,5-dichlorobenzoic acid, N-dimethylaminomethylene-, methyl ester
|
|
5 | -3.86 |
| 37-407-9 |
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-6-(trimethylsilyl)-, (5«alpha»,6«alpha»)-
|
|
5 | -2.60 |
| 37-975-9 |
6Alpha-fluoro-17alpha-hydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
|
|
5 | -4.98 |
| 38-645-4 |
3,5-dimethyl-4-propyl-1H-pyrrole-2-carboxylic acid ethyl ester
|
|
5 | -3.65 |
| 39-682-2 |
allo-Cholanic acid, 3«beta»,12«beta»-dihydroxy, Me-TMS
|
|
5 | -6.65 |
| 39-806-4 |
allo-Cholanic acid, 3«beta»,12«alpha»-dihydroxy, Me-TMS
|
|
5 | -6.65 |
| 39-893-8 |
5«beta»-Androstan-3«alpha»-ol-17-one (Etiocholanolone), MO
|
|
5 | -4.30 |
| 40-260-8 |
allo-Cholanic acid, 3«alpha»,12«beta»-dihydroxy, Me-TMS
|
|
5 | -6.65 |
| 40-271-6 |
2H-Furo[2,3-h]-1-benzopyran-2-one, 5-methoxy-
|
482-48-4 |
5 | -3.73 |
| 40-546-1 |
Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-
|
|
5 | -5.09 |
| 40-832-3 |
Silane, trimethyl[(3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy]-
|
|
5 | -5.67 |
| 40-952-0 |
Phosphoric acid, dimethyl 1-methyl-3-(methylamino)-3-oxo-1-propenyl ester, (Z)-
|
919-44-8 |
5 | 0.33 |
| 41-365-1 |
2-Hydroxymethyl-3-(o-tolyl)-4(3H)-quinazolinone (Methaqualone M)
|
|
5 | -2.94 |
| 41-929-5 |
1,3,5(10)-Oestratriene-3,17«beta»-diol, 3-TMS-17-PFP
|
|
5 | -7.14 |
| 42-453-2 |
N-Isopropyl-N'-methyl-N'-acetyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
5 | -2.54 |
| 42-757-5 |
1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 3-(3-butenyl)-1,2,3,4,5,6-hexahydro-, (1R)-
|
529-78-2 |
5 | -1.23 |
| 43-321-7 |
3H-1,4-Benzodiazepine, 2-amino-7-chloro-5-phenyl-, 4-oxide
|
7722-15-8 |
5 | -3.99 |
| 43-898-8 |
1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-1,3-dimethyl-
|
944-73-0 |
5 | -1.31 |
| 44-618-7 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-E][1,5]diazocin-4-one, 7,7a,8,9,10,11,13,14-octahydro-, [7R-(7«alpha»,7a«alpha»,14«alpha»)]-
|
486-90-8 |
5 | -1.21 |
| 44-963-4 |
1,3-Dioxolo[4,5-g]isoquinolin-5-ol, 5,6,7,8-tetrahydro-6-methyl-
|
6592-85-4 |
5 | -1.57 |
| 48-703-8 |
1,3-Dioxolo[4,5-b]acridin-10(5H)-one, 4,11-dimethoxy-5-methyl-
|
|
5 | -4.08 |
| 49-721-7 |
2-Butenoic acid, 3-[[(ethylamino)methoxyphosphinothioyl]oxy]-, 1-methylethyl ester, (E)-
|
31218-83-4 |
5 | [-3.41; -3.41] |
| 50-933-0 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,1-dimethyl-butyl)-amine
|
|
5 | -4.88 |
| 53-917-5 |
2,6-Pyridinedicarboxylic acid, isobutyl 2-methylhex-3-yl ester
|
|
5 | -4.57 |
| 55-540-1 |
8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2,3,4,5,6-pentafluorobenzoate
|
|
5 | -4.45 |
| 57-247-5 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohepten-1-yl)-5-ethyl-1,3-dimethyl-
|
|
5 | -3.00 |
| 59-998-0 |
(Z)-N-tert-Butyldimethylsilyloxy-1-(4-methoxy-3-nitro-phenyl)ethanimine
|
|
5 | -4.51 |
| 60-022-0 |
1H-Purine-2,6-dione, 7-ethyl-3,7-dihydro-1,3-dimethyl-
|
23043-88-1 |
5 | -0.76 |
| 60-676-5 |
4-Methyl-2-phenyl-1,2,3-triazole-5-carboxylic acid
|
|
5 | -2.16 |
| 60-680-0 |
5«alpha»-Androstan-3«alpha»-ol-17-one (Androsterone), MO
|
|
5 | -4.30 |
| 61-695-3 |
allo-Cholanic acid, 3«alpha»,12«beta»-dihydroxy, Me-DMES
|
|
5 | -6.84 |
| 61-929-3 |
O,O-Diethyl-S-(1,1-difluoro-2-chloroethyl)-dithiophosphate
|
|
5 | -4.78 |
| 62-710-4 |
7H-furo[3,2-g][1]benzopyran-7-one, 9-[(3-methyl-2-butenyl)oxy]-
|
|
5 | -4.23 |
| 63-871-5 |
(E)-N-tert-Butyldimethylsilyloxy-1-(4-methoxy-3-nitrophenyl)ethanimine
|
|
5 | -4.51 |
| 65-887-6 |
allo-Cholanic acid, 3«beta»,7«beta»-dihydroxy, Me-DMES
|
|
5 | -6.74 |
| 66-373-5 |
6-Chloro-N,N'-(1,1,3,3-tetramethylbutyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | -7.44 |
| 66-572-4 |
3«beta»,7«beta»-Dihydroxy-5«beta»-cholanoic acid, MeTMS
|
78964-21-3 |
5 | -6.52 |
| 66-573-3 |
allo-Cholanic acid, 3«alpha»,7«beta»-dihydroxy, Me-TMS
|
|
5 | -6.52 |
| 66-574-2 |
allo-Cholanic acid, 3«beta»,7«alpha»-dihydroxy, Me-TMS
|
|
5 | -6.52 |
| 66-575-1 |
allo-Cholanic acid, 3«alpha»,7«alpha»-dihydroxy, Me-TMS
|
|
5 | -6.52 |
| 68-400-2 |
3H-Pyrimidin-4-one, 2,3:5,6-bis-trimethyleno
|
|
5 | -1.13 |
| 68-568-7 |
1H-2«lambda»*6*-Benzo[2,1,3]thiadiazin-4-one, 3-isopropyl-2,2-dioxo-2,3-dihydro
|
|
5 | -1.63 |
| 68-651-4 |
1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-
|
28822-58-4 |
5 | -1.68 |
| 69-782-8 |
allo-Cholanic acid, 3«alpha»,7«beta»-dihydroxy, Me-DMES
|
|
5 | -6.74 |
| 69-783-7 |
allo-Cholanic acid, 3«beta»,7«alpha»-dihydroxy, Me-DMES
|
|
5 | -6.74 |
| 70-017-5 |
allo-Cholanic acid, 3«beta»,12«alpha»-dihydroxy, Me-DMES
|
|
5 | -6.84 |
| 70-018-4 |
allo-Cholanic acid, 3«beta»,12«beta»-dihydroxy, Me-DMES
|
|
5 | -6.84 |
| 70-698-0 |
1,3,5(10)-Oestratriene-3,17«alpha»-diol, 3-TMS-17-HFB
|
|
5 | -7.78 |
| 71-616-9 |
Estra-1,3,5(10)-trien-17-one, 3,16«alpha»-bis(trimethylsiloxy)-
|
28416-72-0 |
5 | -5.49 |
| 71-897-8 |
3«beta»,7«alpha»-Dihydroxy-5«beta»-cholanoic acid, MeTMS
|
81445-73-0 |
5 | -6.52 |
| 72-200-9 |
Copper,bis(hydrogen 2-hydroxy-e-oxo-1-cyclohexene-1-hexanato)-, dimethyl ester
|
|
5 | -4.55 |
| 72-599-8 |
Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5«alpha»,6«alpha»)-, bis(trifluoroacetate) (ester)
|
66091-22-3 |
5 | -3.78 |
| 74-538-3 |
3-(4-N,N-Dimethylaminophenyl)propenoic acid, 2-(diethoxyphosphinyl)-, ethyl ester
|
66564-08-7 |
5 | -3.37 |
| 78-199-6 |
Succinic acid, hex-4-yn-3-yl 3-phenoxybenzyl ester
|
|
5 | -5.49 |
| 79-455-0 |
P-chloro-n-(2,3,4,4,5,6-hexachloro-2,5-cyclohexadienylidene)aniline
|
|
5 | -7.08 |
| 80-576-4 |
Androst-4-en-3-one, 17-hydroxy-, O-methyloxime, (17«beta»)-
|
3091-89-2 |
5 | -4.37 |
| 80-924-7 |
2-Butene-1,4-disulfonic acid, dimethyl ester (cis and trans)
|
70886-56-5 |
5 | -2.23 |
| 81-930-9 |
3-Hydroxyestra-2,5(10)-diene-1,4,17-trione
|
|
5 | -3.95 |
|
« Previous Results
Next Results »
|